February 18, 2014
Influencing with Integrity: Intention vs. Impact
This evening’s engaging presentation was given by Stephen McGarvey, the founder and managing partner of Solutions in Mind and a world-leading authority on unconscious communication, persuasion, and influence. He has assisted corporations and audiences around the world in solving difficult communications problems.
January 28, 2014
Standing Out in a Sea of Generics: Succeeding in the Loss of Exclusivity Environment
This first meeting of 2014 was moderated by John Oster from Lundbeck Canada and he welcomed three speakers this evening: Ian Johnson, Principal of Commercial Effectiveness Services with IMS, Jefferey Sleep, Manager of Cornerstone with AstraZeneca in Toronto and Rania Cassar-Awe, Director of Retail Strategy at Pfizer. Each of the speakers were given the floor to discuss their experiences in the loss of exclusivity environment.
November 19, 2013
Pan-Canadian Drug Pricing Alliance: How will it unfold?
How ready will you be when PCPA becomes a reality for your brand?
In an evolving regulatory environment, brand pricing and access strategies are continuously being challenged and re-examined to adjust to new government initiatives. This evening’s event was tailored as a group discussion between industry and government stakeholders around the Pan-Canadian Drug Pricing Alliance (PCPA) and to hear new insights from independent research.
October 8, 2013
Frontline Innovation: Empowering Patients to Manage Their Own Health
This evening’s dynamic event was kicked off by our moderator John Oster who began by polling the audience with the following question: “What amount of effort does my company invest in empowering patients to manage their own health?” 50% of respondents answered <10% and 36% answered 10-30%. The key speaker, Dr. Joseph Cafazzo, was then introduced. He is the lead for the Centre for Global eHealth Innovation, a state-of-the-art research facility devoted to the evaluation and design of healthcare technology. He is also the Senior Director of UHN Healthcare Human Factors and an Assistant Professor in the Department of Health Policy, Management and Evaluation, and the Institute of Biomaterials and Biomedical Engineering, Faculty of Medicine, at the University of Toronto. In 2010, he was the recipient of the Career Scientist award by the Ontario Ministry of Health and Long Term Care.
September 18, 2013
Pharmacists: Expanded Scope of Practice Market Revolution?
At the first meeting of the 2013-2014 season, the guest speaker was Bertrand Bolduc. Bertrand is the chairman and a partner at Galenova, Gentes & Bolduc Pharmacists and is also a pharmacist, entrepreneur and former PMCQ president. He has also held marketing positions in pharma and currently sits on the boards of the Ordre des Pharmaciens du Québec, Urgences-Santé, Prevtec and Greenshield.
May 21, 2013
The Global Transformation of Pharma: A Prescription for Canada
At this last meeting of the 2012-2013 season, we had the pleasure of welcoming Russell Williams, the president of Rx&D, as the keynote speaker. His talk focused on the unprecedented changes that the pharma industry is going through worldwide and how that applies to Canada.
April 23, 2013
Building Effective Partnerships for Optimal Patient Care
This month’s meeting took on a different format with a panel of esteemed members who were present to discuss partnerships between patient groups, charitable sectors and the pharma industry. The evening’s moderator was Karen M. Chow, who is responsible for National Stakeholder Relations at Novartis. Karen introduced one of the panel members, Deirdre Freiheit, the Executive Director of the Health Charities Coalition of Canada, who provided the audience with an overview of the charitable and non-profit health sector in Canada.
March 27, 2013
The media challenge!
Maximizing ROI with ROM (Return On Media)
The moderator for this evening’s rousing debate was Rehan Javeri, Director of Sales Effectiveness at Bristol-Myers Squibb Canada. He introduced the two speakers: Regina Kulikowski, President of Regina K Inc. who was going head-to-head against Darcy Kelley, Director of Insights & Strategy at Sonic Boom (a subsidiary of National Public Relations). Regina was arguing in favour of print media while Darcy was supporting digital media channels.
February 12, 2013
Innovation Revolution: Ignite Innovation in Every Aspect of Your Company
The dynamic guest speaker for this month’s meeting was Lisa Bodell, CEO and Founder of futurethink, an internationally recognized innovation research and training firm. She founded her company 15 years ago on the principle that, with the right knowledge and tools, everyone has the power to innovate.
January 15, 2013
Are Private Sector Formularies Set to Align with Public?
This first meeting of 2013 was held in conjunction with the Canadian Association of Healthcare Reimbursement and was moderated by George Wyatt, the managing director of Wyatt Health Management. George was an excellent choice as moderator for this event as he has worked in provincial government as well as various pharmaceutical and biopharmaceutical sectors and serves on the board of directors of the Canadian Association of Healthcare Reimbursement. George introduced the speaker for tonight’s event, Helen Stevenson, the President and CEO of Reformulary Group Inc. Helen is also the former Executive Officer of Ontario Public Drug Programs and Assistant Deputy Minister of Health in Ontario. The Reformulary Group is a company dedicated to managing drug costs for employee drug plans.
November 20, 2012
Career Life Cycle Management
What You Need to Do to Prepare for and Thrive in Pharma
The evening kicked off with Adam Siskind, the Office Managing Principal of ZS Associates in Toronto. His talk began with a quick poll of the audience, asking how optimistic they were about the future of pharma. Forty-two percent responded that they were somewhat optimistic, 12% were very optimistic and 15% were neutral. Despite these responses, Adam felt that there is a lot of excitement in the industry and that it’s the right time to be in it. Pharma no longer has blockbuster drugs, which has changed its focus to specialty areas, such as oncology. As a result, there is now an increasing importance of other roles in organizations. Marketing is far more complex than it has ever been which has led to global opportunities and portfolio diversification.
October 16, 2012
Evolution of the PAAB Code: Revisions to s6.5
The Digital Side of PAAB
This month’s PMCQ meeting went outside the norm of the dinner venue and was a breakfast meeting prior to an all-day Pharmaceutical Advertising Advisory Board (PAAB) training session. The PMCQ meeting began with Ray Chepsiuk, the Commissioner of PAAB, who outlined how section 6.5 of the PAAB code has been revamped. Since the PAAB code was first introduced, there have been a multitude changes in the advertising world, the most important of recent years being the introduction of digital marketing. As a result, in an attempt to “modernize” the code, section 6.5 has been completely rewritten. A committee was developed, which included members of the pharmaceutical industry, who developed the section in collaboration. Responses received through an extensive survey conducted by PAAB a few months ago were also taken into consideration in the section revisions.
September 18, 2012
Is Pharma a Four-Letter Word?
The first meeting of the 2012-2013 season featured guest speaker André Picard, a health reporter and columnist at the The Globe and Mail, an author of three books and a six-time finalist for the National Newspaper Awards. The evening kicked off with a survey of the audience asking if they felt the media provided fair coverage of the pharma industry. Based on the results of the survey, André stated that 79% of respondents felt that the media was a 4-letter word! During his presentation, he set out to change this statistic.